Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis

Background/Objectives: Radiotherapy (RT) is a mainstay of clinical cancer therapy that causes broad immune responses. The complement system is a pivotal effector mechanism in the innate immune response, but the impact of RT is less well understood. This study investigates the interaction between RT...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang, Yingying (Author) , Mai, Lixin (Author) , Schneeweiss, Jonathan M. (Author) , Lopez Perez, Ramon (Author) , Kirschfink, Michael (Author) , Huber, Peter E. (Author)
Format: Article (Journal)
Language:English
Published: 18 July 2025
In: Cancers
Year: 2025, Volume: 17, Issue: 14, Pages: 1-15
ISSN:2072-6694
DOI:10.3390/cancers17142383
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers17142383
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/17/14/2383
Get full text
Author Notes:Yingying Liang, Lixin Mai, Jonathan M. Schneeweiss, Ramon Lopez Perez, Michael Kirschfink and Peter E. Huber

MARC

LEADER 00000naa a2200000 c 4500
001 1944461256
003 DE-627
005 20251204172610.0
007 cr uuu---uuuuu
008 251204s2025 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers17142383  |2 doi 
035 |a (DE-627)1944461256 
035 |a (DE-599)KXP1944461256 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Liang, Yingying  |d 1984-  |e VerfasserIn  |0 (DE-588)1119366852  |0 (DE-627)872720098  |0 (DE-576)479838674  |4 aut 
245 1 0 |a Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis  |c Yingying Liang, Lixin Mai, Jonathan M. Schneeweiss, Ramon Lopez Perez, Michael Kirschfink and Peter E. Huber 
264 1 |c 18 July 2025 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.12.2025 
520 |a Background/Objectives: Radiotherapy (RT) is a mainstay of clinical cancer therapy that causes broad immune responses. The complement system is a pivotal effector mechanism in the innate immune response, but the impact of RT is less well understood. This study investigates the interaction between RT and the complement system as a possible approach to improve immune responses in cancer treatment. Methods: Human solid cancer (lung, prostate, liver, breast cancer), lymphoma, and leukemia cells were irradiated using X-rays and treated with polyclonal antibodies or anti-CD20 monoclonal antibodies, respectively. Chromium release assay was applied to measure cell lysis after radiation with or without complement-activating antibody treatment. The expression of membrane-bound complement regulatory proteins (mCRPs; CD46, CD55, CD59), which confer resistance against complement activation, CD20 expression, apoptosis, and radiation-induced DNA double-strand breaks (γH2AX), was measured by flow cytometry. The radiosensitivity of tumor cells was assessed by colony-forming assay. Results: We demonstrate that RT profoundly impacts complement function by upregulating the expression of membrane-bound complement regulatory proteins (mCRPs) on tumor cells in a dose- and time-dependent manner. Impaired complement-mediated tumor cell lysis could thus potentially contribute to radio-therapeutic resistance. We also observed RT-induced upregulation of CD20 expression on lymphoma and leukemic cells. Notably, complement activation prior to RT proved more effective in inducing RT-dependent early apoptosis compared to post-irradiation treatment. While complement modulation does not significantly alter RT-induced DNA-damage repair mechanisms or intrinsic radiosensitivity in cancer cells, our results suggest that combining RT with complement-based anti-cancer therapy may enhance complement-dependent cyto-toxicity (CDC) and apoptosis in tumor cells. Conclusions: This study sheds light on the complex interplay between RT and the complement system, offering insights into potential novel combinatorial therapeutic strategies and a potential sequential structure for certain tumor types. 
650 4 |a CD20 
650 4 |a complement activation 
650 4 |a complement-dependent cytotoxicity (CDC) 
650 4 |a DNA-damage repair 
650 4 |a membrane-bound complement regulatory proteins (mCRPs) 
650 4 |a radiosensitivity 
650 4 |a radiotherapy 
650 4 |a timing 
700 1 |a Mai, Lixin  |e VerfasserIn  |0 (DE-588)1383439206  |0 (DE-627)194446235X  |4 aut 
700 1 |a Schneeweiss, Jonathan M.  |e VerfasserIn  |4 aut 
700 1 |a Lopez Perez, Ramon  |e VerfasserIn  |0 (DE-588)1071675222  |0 (DE-627)82624646X  |0 (DE-576)433243996  |4 aut 
700 1 |a Kirschfink, Michael  |e VerfasserIn  |0 (DE-588)120927152  |0 (DE-627)080974457  |0 (DE-576)292452411  |4 aut 
700 1 |a Huber, Peter E.  |d 1965-  |e VerfasserIn  |0 (DE-588)1074678869  |0 (DE-627)832350109  |0 (DE-576)442767803  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 17(2025), 14, Artikel-ID 2383, Seite 1-15  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis 
773 1 8 |g volume:17  |g year:2025  |g number:14  |g elocationid:2383  |g pages:1-15  |g extent:15  |a Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis 
856 4 0 |u https://doi.org/10.3390/cancers17142383  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/17/14/2383  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251204 
993 |a Article 
994 |a 2025 
998 |g 1074678869  |a Huber, Peter E.  |m 1074678869:Huber, Peter E.  |d 50000  |d 910000  |d 911400  |e 50000PH1074678869  |e 910000PH1074678869  |e 911400PH1074678869  |k 0/50000/  |k 0/910000/  |k 1/910000/911400/ 
998 |g 120927152  |a Kirschfink, Michael  |m 120927152:Kirschfink, Michael  |d 50000  |e 50000PK120927152  |k 0/50000/ 
998 |g 1383439206  |a Mai, Lixin  |m 1383439206:Mai, Lixin  |d 50000  |e 50000PM1383439206  |k 0/50000/  |p 2 
999 |a KXP-PPN1944461256  |e 4821629267 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"note":["Gesehen am 27.05.2020"],"pubHistory":["1.2009 -"],"language":["eng"],"disp":"Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysisCancers","name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"origin":[{"publisher":"MDPI","publisherPlace":"Basel","dateIssuedKey":"2009","dateIssuedDisp":"2009-"}],"recId":"614095670","id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Cancers","title_sort":"Cancers"}],"part":{"text":"17(2025), 14, Artikel-ID 2383, Seite 1-15","volume":"17","extent":"15","pages":"1-15","year":"2025","issue":"14"}}],"physDesc":[{"extent":"15 S.","noteIll":"Illustrationen"}],"title":[{"title":"Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis","title_sort":"Radiotherapy upregulates the expression of membrane-bound negative complement regulator proteins on tumor cells and limits complement-mediated tumor cell lysis"}],"note":["Gesehen am 04.12.2025"],"language":["eng"],"person":[{"role":"aut","family":"Liang","display":"Liang, Yingying","given":"Yingying"},{"given":"Lixin","role":"aut","family":"Mai","display":"Mai, Lixin"},{"given":"Jonathan M.","display":"Schneeweiss, Jonathan M.","family":"Schneeweiss","role":"aut"},{"given":"Ramon","role":"aut","family":"Lopez Perez","display":"Lopez Perez, Ramon"},{"family":"Kirschfink","role":"aut","display":"Kirschfink, Michael","given":"Michael"},{"given":"Peter E.","family":"Huber","role":"aut","display":"Huber, Peter E."}],"recId":"1944461256","id":{"eki":["1944461256"],"doi":["10.3390/cancers17142383"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Yingying Liang, Lixin Mai, Jonathan M. Schneeweiss, Ramon Lopez Perez, Michael Kirschfink and Peter E. Huber"]},"origin":[{"dateIssuedDisp":"18 July 2025","dateIssuedKey":"2025"}]} 
SRT |a LIANGYINGYRADIOTHERA1820